December 06, 2013
1 min read
Save

Study: Non-fatal VTE does not impact clinical outcomes in patients 2 years after TKA

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Non-fatal venous thromboembolism does not impact clinical outcomes in patients 2 years following total knee arthroplasty, according to a study from researchers from Hospital for Special Surgery.

“Patients that suffer these unfortunate complications, although at risk for significant morbidity, do not appear to have inferior clinical outcomes 2 years following surgery,” Michael P. Ast, MD, and colleagues wrote in the study. “While [venous thromboembolism] VTE events hold important clinical significance, the results of this study provide the arthroplasty surgeon with evidence of the potential clinical outcomes following these serious complications. This information can assist in counseling patients in regards to their expected outcomes after appropriate treatment for VTE following total knee arthroplasty.”

Ast and colleagues used the Hospital for Special Surgery joint registry to analyze 80 patients who experienced VTE after total knee arthroplasty (TKA) matched against 480 patients in a control group who did not have any complications. There were no significant differences between WOMAC and SF-12 scores in either group at the 2-year follow-up.

Disclosure: One author (Westrich) is a paid consultant for Stryker, Exactech and DJO and receives research support from Stryker and Exactech.